Chelation for heavy metals (arsenic, lead, and mercury): protective or perilous?
Despite clinical experience that spans more than half a century, chelation for toxic heavy metals represents one of the most controversial and misapplied interventions in clinical toxicology. The prompt use of chelating agents to treat acute, life-threatening intoxication is an indication that is largely supported by experimental animal data and limited clinical research. Although chelating agents administered for chronic intoxication may accelerate the excretion of heavy metals, their therapeutic efficacy in terms of decreased morbidity and mortality is largely unestablished. Recent investigations suggest that their use in such settings might be associated with deleterious effects. Careful attention to risk-benefit issues is warranted, particularly in clinical situations in which the etiological role of heavy metals in the patient's illness is in question.
Kosnett
M J
MJ
Division of Clinical Pharmacology & Toxicology, Department of Medicine, University of Colorado Denver, Denver, Colorado, USA. Michael.Kosnett@ucdenver.edu
D000208:Acute Disease; D000818:Animals; D020261:Arsenic Poisoning / Q000188:drug therapy* / Q000503:physiopathology; D002614:Chelating Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D000075322:Heavy Metal Poisoning; D006801:Humans; D007855:Lead Poisoning / Q000188:drug therapy* / Q000503:physiopathology; D008630:Mercury Poisoning / Q000188:drug therapy* / Q000503:physiopathology; D013997:Time Factors
D002614:Chelating Agents